H.U. Group Holdings Inc
TSE:4544
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (0.7), the stock would be worth ¥3 137.52 (2% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.7 | ¥3 192 |
0%
|
| 3-Year Average | 0.7 | ¥3 137.52 |
-2%
|
| 5-Year Average | 0.7 | ¥3 056.88 |
-4%
|
| Industry Average | 1.7 | ¥7 294.35 |
+129%
|
| Country Average | 1.1 | ¥4 762.94 |
+49%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
¥188.2B
|
/ |
Jan 2026
¥247.7B
|
= |
|
|
¥188.2B
|
/ |
Mar 2026
¥253.6B
|
= |
|
|
¥188.2B
|
/ |
Mar 2027
¥260.4B
|
= |
|
|
¥188.2B
|
/ |
Mar 2028
¥273.7B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
H.U. Group Holdings Inc
TSE:4544
|
177.1B JPY | 0.7 | 31.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.6B USD | 0.4 | 58.2 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 0.4 | 13.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.4B USD | 0 | 12.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.8B EUR | 1.5 | 23.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23B EUR | 1.4 | 18.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 2.3 | 21.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.8 | 24.3 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.9 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | 11.5 | -25.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 1.4 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.1 |
| 70th Percentile | 2 |
| Max | 12 107 466 |
Other Multiples
H.U. Group Holdings Inc
Glance View
H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Shinjuku, Tokyo-To and currently employs 5,897 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
